EMERYVILLE, Calif., Nov. 1, 2022
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading
synthetic biotechnology company accelerating the world's transition
to sustainable consumption through its Lab-to-MarketTM
technology platform and clean beauty consumer brands, today
announced that it will issue its financial results for the third
quarter ended September 30, 2022, on
the afternoon of Tuesday, November 8,
2022, after closing of the financial markets.
The company will hold a conference call and webcast at
1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which,
John Melo, President and Chief
Executive Officer, and Han
Kieftenbeld, Chief Financial Officer, will discuss Amyris'
financial results and provide an update on the company's business.
Participants may access the live webcast on Amyris' Investor
Relations website, where it will be archived for 90 days. The live
call can be accessed by dialing (844) 850-0551 (domestic) or (412)
902-4203 (international) and asking to join the Amyris, Inc.
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology
company, transitioning the Clean Health & Beauty and Flavors
& Fragrances markets to sustainable ingredients through
fermentation and the company's proprietary
Lab-to-MarketTM technology platform. This Amyris
platform leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
Amyris, the Amyris logo, Biossance, Costa Brazil, JVN,
Lab-to-Market, Pipette, and Rose Inc. are trademarks or registered
trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or
View original content to download
SOURCE Amyris, Inc.